Sotera Health (NASDAQ:SHC) Stock Rating Upgraded by Citigroup

Sotera Health (NASDAQ:SHC – Get Free Report) was upgraded by Citigroup from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, Marketbeat Ratings reports. The brokerage currently has a $16.00 price objective on the stock, down from their previous price objective of $18.00. Citigroup’s target price indicates a potential upside […]

Related Keywords

Canada ,United States ,Dekabank Deutsche Girozentrale ,Michaelp Rutz ,Securities Exchange Commission ,Charles Schwab Investment Management Inc ,Barclays ,Roubaix Capital ,Sotera Health ,Tudor Investment Corp Et Al ,Royal Bank ,Sotera Health Company ,Analyst Recommendations For Sotera Health ,Jefferies Financial Group ,Institutional Investors Weigh In On Sotera Health ,Sotera Health Company Profile ,Keycorp ,Sotera Health Price Performance ,Citigroup ,News Ratings For Sotera Health Daily ,Pincus Co ,Get Free Report ,Marketbeat Ratings ,Financial Group ,Director Pincus ,Exchange Commission ,Schwab Investment Management ,Bank Deutsche Girozentrale ,Untitled Investments ,Health Company ,Sotera Health Daily ,Nasdaq Shc ,Shc ,Medical ,Upgrade ,Citigroup Inc ,